You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 8, 2025

Claims for Patent: 9,352,041

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,352,041

Title:	Use of an oleogel containing triterpene for healing wounds
Abstract:	An oleogel comprising a non-polar liquid and a powder containing triterpene is provided as an oleogel that may be used for healing wounds.
Inventor(s):	Scheffler Armin
Assignee:	BIRKEN AG
Application Number:	US13509416
Patent Claims:	2. The method of claim 1 , wherein the area of epidermolysis bullosa comprises blisters.3. The method of claim 1 , wherein the powder comprises betulin and lupeol.4. The method of claim 3 , wherein the joint fraction of betulin and lupeol in the powder is greater than 80 weight-percent.5. The method of claim 3 , wherein the joint fraction of betulin and lupeol in the powder is greater than 85 weight-percent.6. The method of claim 1 , wherein the oleogel further comprises a nonpolar liquid.7. The method of claim 6 , wherein the nonpolar liquid comprises a fraction of between 80 weight-percent and 99 weight-percent in relation to the total weight of the oleogel claim 6 , and wherein the powder comprises a fraction of between 1 weight-percent and 20 weight-percent in relation to the total weight of the oleogel.8. The method of claim 6 , wherein the nonpolar liquid is a plant claim 6 , animal claim 6 , mineral claim 6 , or synthetic oil.9. The method of claim 8 , wherein the plant oil is a vegetable oil which is selected from one of the following: sunflower oil claim 8 , olive oil claim 8 , avocado oil claim 8 , and almond oil.10. The method of claim 1 , wherein the fraction of betulin in the powder is greater than 60 weight-percent.11. The method of claim 1 , wherein a mean particle size of the powder is between 20 nm and 50 μm.12. The method of claim 1 , wherein a mean particle size of the powder is less than 10 μm.13. The method of claim 1 , wherein the oleogel includes an additional wound healing substance.14. The method of claim 1 , wherein the powder further comprises betulinic acid claim 1 , oleanolic acid claim 1 , and erythrodiol.15. The method of claim 1 , wherein the patient is a human.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.